Trifarotene: A Novel Therapeutic Option for Acne
Acne vulgaris, or acne, is a prevailing cutaneous predicament that customarily crops up on the face, neck, and trunk in the forms of comedones, papules, pustules, and nodules. According to epidemiologic explorations, acne affects 9.4% of the global population, making it the eighth most common diseas...
Saved in:
Main Author: | Piyu Parth Naik (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessing the Safety and Efficacy of Trifarotene in the Treatment of Acne Vulgaris
by: Brumfiel CM, et al.
Published: (2021) -
Comparison of the Efficacy of Clascoterone, Trifarotene, and Tazarotene for the Treatment of Acne: A Systematic Literature Review and Meta-Analysis
by: Mahek Shergill, et al.
Published: (2024) -
Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study
by: Stephen Schleicher, et al.
Published: (2023) -
A contemporary snippet on clinical presentation and management of toxic epidermal necrolysis
by: Piyu Parth Naik
Published: (2022) -
Correction: Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study
by: Stephen Schleicher, et al.
Published: (2024)